Home > Income Statement > SENORES PHARMACEUTICALS

SENORES PHARMACEUTICALS
Revenue

    Back to Income Statement
SENORES PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SENORES PHARMACEUTICALS
Please provide your vote to see the results

SENORES PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022
Net Sales ₹398 Cr₹215 Cr₹35 Cr₹14 Cr

What is the latest Revenue of SENORES PHARMACEUTICALS ?

The latest Revenue ratio of SENORES PHARMACEUTICALS is ₹398 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹398 Cr
Mar2024₹215 Cr
Mar2023₹35 Cr
Mar2022₹14 Cr

How is Revenue of SENORES PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹398 Cr
85.65
Mar2024 ₹215 Cr
507.07
Mar2023 ₹35 Cr
149.38
Mar2022 ₹14 Cr -

Compare Revenue of peers of SENORES PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS ₹7,128.7 Cr 4.8% 10.5% 126.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,675.0 Cr -3% -2.6% 21.3% Stock Analytics
DIVIS LABORATORIES ₹225,516.0 Cr -0.5% 17% 43.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹186,190.0 Cr 0.6% 2.7% 35.5% Stock Analytics
CIPLA ₹115,523.0 Cr -2.2% 0.8% -2.4% Stock Analytics
DR REDDYS LABORATORIES ₹99,493.4 Cr -1.1% -1.6% -0.8% Stock Analytics


SENORES PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SENORES PHARMACEUTICALS

4.8%

10.5%

126.7%

SENSEX

-1%

0.7%

-3.6%


You may also like the below Video Courses